Table 1.
Oxidative-stress associated extracellular miRNAs
| Focused organs/diseases | miRNAs | References |
|---|---|---|
| Central nervous system/Stroke | miR-4639-3p, miR-1-3p, miR-17-5p, miR-20a-5p, miR-20b-5p, miR-99a-5p, miR-106b-5p, miR-126-3p, miR-129-5p, miR-181c-5p, miR-300-3p, miR-369-3p, miR-410-3p, miR-451a, miR-499a-5p, miR-219a-5p | (Pusic, 2014; Pusic, 2015; Tao, 2015; Ma, 2016; Pusic, 2016; Chen, 2017a; Chen, 2017b; Li, 2017b; Phillips, 2017) |
| Cardiovascular diseases | miR-92a-3p, miR-126-3p, miR-129-5p, miR-155-5p, miR-210-3p, miR-21-5p, miR-29a-3p, miR-17-3p | (Wang, 2013; Curti, 2014; Chen, 2015; da Silva, 2015; Wang, 2015; Yamaguchi, 2015; DuPont, 2016; Wu, 2016; Xiao, 2016; Liu, 2017; Ramachandran, 2017) |
| Liver | miR-122-5p, miR-192-5p, miR-223-3p, miR-1224-5p | (Roy, 2016; Li, 2017a; Mosedale, 2017; Roy, 2017) |
| Kidney | miR-15a-5p, miR-92a-3p | (Kamalden, 2017; Shang, 2017) |
| Peripheral blood, bone marrow | miR-96-5p, miR-182-5p, miR-183-5p, miR-17-3p | (Curti, 2014; Davis, 2017) |
| Sepsis | miR-1-3p, miR-25-3p | (Yao, 2015; Xu, 2017) |
| Diabetes | miR-126-3p | (Wu, 2016) |
| Lung | miR-320a, miR-221-3p | (Lee, 2016) |
| Hyperlipidemia | miR-33a-5p, miR-33b-5p, miR-200c-3p | (D'Agostino, 2017) |
| Skin/Vitiligo | miR-25-3p | (Shi, 2016) |